We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-1.36%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.32B
AUM Growth
-$280M
Cap. Flow
-$198M
Cap. Flow %
-15.04%
Top 10 Hldgs %
17.04%
Holding
1,626
New
448
Increased
346
Reduced
313
Closed
483

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$9.86M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$9.7M
3
CNR
Core Natural Resources Inc
CNR
+$8.26M
4
BIO icon
Bio-Rad Laboratories Class A
BIO
+$6.63M
5
ORCL icon
Oracle
ORCL
+$6.25M

Top Sells

Rank Stock Value
1
SMAR
Smartsheet Inc.
SMAR
+$14M
2
HTLF
Heartland Financial USA, Inc.
HTLF
+$11.1M
3
NVDA icon
NVIDIA
NVDA
+$9.36M
4
AMZN icon
Amazon
AMZN
+$8.75M
5
NFLX icon
Netflix
NFLX
+$8.58M

Sector Composition

Rank Sector Weight
1 Technology 13.2%
2 Healthcare 10.48%
3 Consumer Discretionary 9.93%
4 Financials 7.26%
5 Communication Services 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WM icon
826
Waste Management
WM
$91.4B
$236K 0.02%
1,019
-1,191
-54% -$264K
NBIX icon
827
Neurocrine Biosciences
NBIX
$16.6B
$236K 0.02%
+2,132
New +$270K
KLC
828
KinderCare Learning Companies
KLC
$583M
$235K 0.02%
+20,309
New +$376K
JAKK icon
829
Jakks Pacific
JAKK
$292M
$235K 0.02%
9,539
-11,607
-55% -$328K
HBAN icon
830
Huntington Bancshares
HBAN
$35.8B
$235K 0.02%
+15,667
New +$252K
STZ icon
831
Constellation Brands
STZ
$22.7B
$235K 0.02%
1,280
-2,838
-69% -$516K
TMHC
832
DELISTED
Taylor Morrison
TMHC
$235K 0.02%
+3,911
New +$243K
GD icon
833
General Dynamics
GD
$106B
$234K 0.02%
+860
New +$224K
TRV icon
834
Travelers Companies
TRV
$78.7B
$234K 0.02%
+886
New +$221K
ARDT
835
Ardent Health
ARDT
$1.59B
$234K 0.02%
+17,000
New +$248K
TTEC icon
836
TTEC Holdings
TTEC
$83.2M
$233K 0.02%
70,929
+26,580
+60% +$98.1K
DVAX
837
DELISTED
Dynavax Technologies
DVAX
$233K 0.02%
+17,964
New +$238K
EVH icon
838
Evolent Health
EVH
$476M
$232K 0.02%
+24,490
New +$247K
SFM icon
839
Sprouts Farmers Market
SFM
$7.8B
$232K 0.02%
1,519
-1,536
-50% -$229K
U icon
840
Unity
U
$18.9B
$232K 0.02%
+11,835
New +$267K
MGRC icon
841
McGrath RentCorp
MGRC
$2.96B
$232K 0.02%
2,081
-1,086
-34% -$128K
COYA icon
842
Coya Therapeutics
COYA
$111M
$231K 0.02%
35,770
– –
AD
843
Array Digital Infrastructure
AD
$3.05B
$231K 0.02%
+3,335
New +$216K
KMPR icon
844
Kemper
KMPR
$1.56B
$230K 0.02%
3,447
-1,115
-24% -$74K
GL icon
845
Globe Life
GL
$14.2B
$230K 0.02%
1,749
-649
-27% -$79.4K
ON icon
846
ON Semiconductor
ON
$31.6B
$230K 0.02%
+5,656
New +$285K
CTAS icon
847
Cintas
CTAS
$82.5B
$230K 0.02%
1,119
-3,266
-74% -$651K
GDX icon
848
CALL
VanEck Gold Miners ETF
GDX
$27.5B
$230K 0.02%
5,000
-81,100
-94% -$3.28M
HRMY icon
849
Harmony Biosciences
HRMY
$2.28B
$230K 0.02%
+6,920
New +$248K
KO icon
850
Coca-Cola
KO
$374B
$230K 0.02%
3,205
-20,635
-87% -$1.38M
32 33
34
35 36

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Prelude Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Prelude Capital Management held 1,626 positions worth $1.32B, down 18% from $1.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Prelude Capital Management withdrew a net $198M in Q1 2025, closing 483 positions and reducing 313 holdings. Its most notable exit was Smartsheet Inc., an estimated $14M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in Intra-Cellular Therapies Inc. worth $10.4M.

  • Prelude Capital Management's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 79,142 shares worth $10.4M.
  • Prelude Capital Management added most to Alphabet (Google) Class A in Q1 2025, an estimated $9.7M increase.
  • Prelude Capital Management's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $9.36M.
  • Prelude Capital Management fully exited Smartsheet Inc. in Q1 2025, selling an estimated $14M.
  • Prelude Capital Management's ten largest holdings make up 17% of its $1.32B portfolio in Q1 2025.
  • Prelude Capital Management opened 448 new positions and closed 483 in Q1 2025.
  • Prelude Capital Management's portfolio value fell 18% quarter-over-quarter to $1.32B.

Based on Prelude Capital Management's 13F filing for Q1 2025, filed 15 May 2025.